BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210114T134500
DTEND;TZID=Europe/London:20210114T144500
DTSTAMP:20260409T130930
CREATED:20201112T074036Z
LAST-MODIFIED:20201112T074036Z
UID:18429-1610631900-1610635500@staging.medilinkmidlands.com
SUMMARY:WEBINAR: The UKCA Mark (implications on medical devices and product import/export)
DESCRIPTION:The UK has left the EU and part of that transition is the establishment of a UK based alternative to the European CE mark. \nIn this Medilink Midlands webinar\, regulatory affairs expert Richard Young will explore the requirements for the UKCA mark\, the time frames associated with this transition\, and the strategic considerations organisations should be planning for if they wish to maintain access to the UK market going forward. \nThe session is intended for business\, Quality\, and Regulatory leaders and will feature 40 minutes of presentation followed by a 20 minute Q&A session. \nDuration: 1 hour \nCLICK HERE TO SECURE YOUR PLACE\n\nSpeaker Profile:\n\nRichard Young\, Managing Director\, Acclaim Biomedical Consulting Ltd\nRichard has an extensive background in regulatory affairs in addition to GMP (quality assurance)\, GLP (laboratory testing)\, and GCP (clinical). Spanning over two decades\, these core skill areas have been developed with experience in products ranging from class 3 devices such as Orthopaedic implants (IIb) neurological robots\, through electromedical devices such as infusion systems and cardiovascular products. \nRichard brings a blend of pragmatism and experience to these disciplines that facilitate insightful problem-solving approaches as well as solid solutions. \nRichard’s skills and experience includes such areas as the development and implementation of effective quality management systems\, auditing to ISO and FDA QSIT standards\, and operating at national and international level through industry associations including Eucomed\, ABHI and ABHI Technical Policy Group.
URL:https://staging.medilinkmidlands.com/event/webinar-the-ukca-mark-implications-on-medical-devices-and-product-import-export/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final-transparent.png
ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk
END:VEVENT
END:VCALENDAR